Literature DB >> 33604177

Quantifying upper limb motor impairment in people with Parkinson's disease: a physiological profiling approach.

Lewis A Ingram1,2, Vincent K Carroll3,4, Annie A Butler1,2, Matthew A Brodie1,2, Simon C Gandevia1,2, Stephen R Lord1,2.   

Abstract

BACKGROUND: Upper limb motor impairments, such as slowness of movement and difficulties executing sequential tasks, are common in people with Parkinson's disease (PD).
OBJECTIVE: To evaluate the validity of the upper limb Physiological Profile Assessment (PPA) as a standard clinical assessment battery in people with PD, by determining whether the tests, which encompass muscle strength, dexterity, arm stability, position sense, skin sensation and bimanual coordination can (a) distinguish people with PD from healthy controls, (b) detect differences in upper limb test domains between "off" and "on" anti-Parkinson medication states and (c) correlate with a validated measure of upper limb function.
METHODS: Thirty-four participants with PD and 68 healthy controls completed the upper limb PPA tests within a single session.
RESULTS: People with PD exhibited impaired performance across most test domains. Based on validity, reliability and feasibility, six tests (handgrip strength, finger-press reaction time, 9-hole peg test, bimanual pole test, arm stability, and shirt buttoning) were identified as key tests for the assessment of upper limb function in people with PD.
CONCLUSIONS: The upper limb PPA provides a valid, quick and simple means of quantifying specific upper limb impairments in people with PD. These findings indicate clinical assessments should prioritise tests of muscle strength, unilateral movement and dexterity, bimanual coordination, arm stability and functional tasks in people with PD as these domains are the most commonly and significantly impaired. ©2021 Ingram et al.

Entities:  

Keywords:  Hypokinesia; Levodopa; Movement disorders; Parkinson disease; Tremor; Upper extremity

Year:  2021        PMID: 33604177      PMCID: PMC7869669          DOI: 10.7717/peerj.10735

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  69 in total

Review 1.  Clinical and pathological features of Parkinson's disease.

Authors:  Susanne A Schneider; Jose A Obeso
Journal:  Curr Top Behav Neurosci       Date:  2015

2.  Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

Authors:  S L Pullman; R L Watts; J L Juncos; T N Chase; J N Sanes
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

Review 3.  Kinesthetic Senses.

Authors:  Uwe Proske; Simon C Gandevia
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

4.  Timed motor tests can detect subtle motor dysfunction in early Parkinson's disease.

Authors:  Charlotte A Haaxma; Bastiaan R Bloem; Sebastiaan Overeem; George F Borm; Martin W I M Horstink
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 5.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

6.  Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease.

Authors:  S E Starkstein; M Esteguy; M L Berthier; H Garcia; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

7.  Hand strength and dexterity.

Authors:  M Kellor; J Frost; N Silberberg; I Iversen; R Cummings
Journal:  Am J Occup Ther       Date:  1971-03

8.  Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment.

Authors:  J Harrison; L Henderson; C Kennard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

9.  Movement disorders in people with Parkinson disease: a model for physical therapy.

Authors:  M E Morris
Journal:  Phys Ther       Date:  2000-06

10.  Analysis of finger-tapping movement.

Authors:  Akos Jobbágy; Péter Harcos; Robert Karoly; Gábor Fazekas
Journal:  J Neurosci Methods       Date:  2005-01-30       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.